Potential regulatory role of the Nrf2/HMGB1/TLR4/NF-κB signaling pathway in lupus nephritis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential regulatory role of the Nrf2/HMGB1/TLR4/NF-κB signaling pathway in lupus nephritis
Authors
Keywords
-
Journal
Pediatric Rheumatology
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-23
DOI
10.1186/s12969-023-00909-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Belimumab for the treatment of pediatric patients with lupus nephritis
- (2023) William Stohl et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Rituximab Biosimilar BCD020 Shows Superior Efficacy above Conventional Non-Biologics Treatment in Pediatric Lupus Nephritis: The Data of Retrospective Cohort Study
- (2023) Mikhail Kostik et al. Biomedicines
- The Potential of Nrf2 Activation as a Therapeutic Target in Systemic Lupus Erythematosus
- (2022) Michelle T. Barati et al. Metabolites
- Recent Advances in Understanding Nrf2 Agonism and Its Potential Clinical Application to Metabolic and Inflammatory Diseases
- (2022) Min-Ji Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Working Towards a Treat-to-Target Protocol in Juvenile Proliferative Lupus Nephritis – A Survey of Pediatric Rheumatologists and Nephrologists in Germany and Austria
- (2022) Kristina Vollbach et al. Frontiers in Pediatrics
- Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway
- (2022) Shengnan Liu et al. Redox Biology
- Clinical Research Progress of Small Molecule Compounds Targeting Nrf2 for Treating Inflammation-Related Diseases
- (2022) Zhenzhen Zhai et al. Antioxidants
- Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study
- (2022) Jingru Tian et al. ANNALS OF THE RHEUMATIC DISEASES
- Diagnostic accuracy of the American College of Rheumatology-1997, the Systemic Lupus International Collaborating Clinics-2012, and the European League Against Rheumatism-2019 criteria for juvenile systemic lupus erythematosus: A systematic review and network meta-analysis
- (2022) Ling-Sai Chang et al. AUTOIMMUNITY REVIEWS
- The Time-Course of Antioxidant Irisin Activity: Role of the Nrf2/HO-1/HMGB1 Axis
- (2021) Agnieszka Irena Mazur-Bialy et al. Antioxidants
- Reduning injection and its effective constituent luteoloside protect against sepsis partly via inhibition of HMGB1/TLR4/NF-κB/MAPKs signaling pathways
- (2021) Zheng Wang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Redox-sensitive Nrf2 and MAPK signaling pathways contribute to trichloroethene-mediated autoimmune disease progression
- (2021) Nivedita Banerjee et al. TOXICOLOGY
- IFN-I Mediates Lupus Nephritis From the Beginning to Renal Fibrosis
- (2021) Xuewei Ding et al. Frontiers in Immunology
- Molecular basis for the disruption of Keap1–Nrf2 interaction via Hinge & Latch mechanism
- (2021) Yuta Horie et al. Communications Biology
- Extracellular HMGB1 augments macrophage inflammation by facilitating the endosomal accumulation of ALD-DNA via TLR2/4-mediated endocytosis
- (2021) Jincheng Lu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Extracellular HMGB1 Induced Glomerular Endothelial Cell Injury via TLR4/MyD88 Signaling Pathway in Lupus Nephritis
- (2021) Tian Yu et al. MEDIATORS OF INFLAMMATION
- Sodium Butyrate Alleviates Intestinal Inflammation in Mice with Necrotizing Enterocolitis
- (2021) Qian Sun et al. MEDIATORS OF INFLAMMATION
- Folic Acid Protects Melanocytes from Oxidative Stress via Activation of Nrf2 and Inhibition of HMGB1
- (2021) Pengran Du et al. Oxidative Medicine and Cellular Longevity
- Oxidative stress, inflammation and disease activity biomarkers in lupus nephropathy
- (2020) N Bona et al. LUPUS
- HMGB1 in Systemic Lupus Erythematosus
- (2020) Tianye Liu et al. Frontiers in Immunology
- NRF2, a Transcription Factor for Stress Response and Beyond
- (2020) Feng He et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Update οn the diagnosis and management of systemic lupus erythematosus
- (2020) Antonis Fanouriakis et al. ANNALS OF THE RHEUMATIC DISEASES
- Toll-like receptor signalling in B cells during systemic lupus erythematosus
- (2020) Simon Fillatreau et al. Nature Reviews Rheumatology
- Immunological pathogenesis and treatment of systemic lupus erythematosus
- (2019) Lu Pan et al. World Journal of Pediatrics
- Diagnostic value of serum high‐mobility group box‐1 in pediatric systemic lupus erythematosus
- (2019) Elham Hossny et al. International Journal of Rheumatic Diseases
- Research priorities in childhood-onset lupus: results of a multidisciplinary prioritization exercise
- (2019) Stacy P. Ardoin et al. Pediatric Rheumatology
- Identification of Renal Long Non-coding RNA RP11-2B6.2 as a Positive Regulator of Type I Interferon Signaling Pathway in Lupus Nephritis
- (2019) Zhuojun Liao et al. Frontiers in Immunology
- Dietary oleuropein and its new acyl-derivate, attenuate murine lupus nephritis through HO-1/Nrf2 activation and suppressing JAK/STAT, NF-κB, MAPK and NLRP3 inflammasome signaling pathways
- (2019) M.L. Castejon et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- HMGB1–C1q complexes regulate macrophage function by switching between leukotriene and specialized proresolving mediator biosynthesis
- (2019) Tianye Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Co-Delivery Of Dihydroartemisinin And HMGB1 siRNA By TAT-Modified Cationic Liposomes Through The TLR4 Signaling Pathway For Treatment Of Lupus Nephritis
- (2019) Lu Diao et al. International Journal of Nanomedicine
- Neutrophil extracellular traps are a source of extracellular HMGB1 in lupus nephritis: associations with clinical and histopathological features
- (2019) L P Whittall-García et al. LUPUS
- Nuclear factor erythroid 2-related factor 2 as a treatment target of kidney diseases
- (2019) Marie Ito et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- HMGB1 was negatively regulated by HSF1 and mediated the TLR4/MyD88/NF-κB signal pathway in asthma
- (2019) Liqun Shang et al. LIFE SCIENCES
- TLR4+CXCR4+plasma cells drive nephritis development in systemic lupus erythematosus
- (2018) Kongyang Ma et al. ANNALS OF THE RHEUMATIC DISEASES
- Nrf2 as a therapeutic target for rheumatic diseases
- (2018) María Luisa Ferrándiz et al. BIOCHEMICAL PHARMACOLOGY
- Nrf2, the Master Regulator of Anti-Oxidative Responses
- (2017) Sandra Vomund et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/ lpr Lupus-Prone Mice
- (2017) Haruki Watanabe et al. Molecular Therapy-Methods & Clinical Development
- Transcriptional Regulation by Nrf2
- (2017) Claudia Tonelli et al. ANTIOXIDANTS & REDOX SIGNALING
- Dietary extra virgin olive oil attenuates kidney injury in pristane-induced SLE model via activation of HO-1/Nrf-2 antioxidant pathway and suppression of JAK/STAT, NF-κB and MAPK activation
- (2016) Marina Aparicio-Soto et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Of Inflammasomes and Alarmins: IL-1 and IL-1 in Kidney Disease
- (2016) H.-J. Anders JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Lung endothelial barrier protection by resveratrol involves inhibition of HMGB1 release and HMGB1-induced mitochondrial oxidative damage via an Nrf2-dependent mechanism
- (2015) Wen-Wen Dong et al. FREE RADICAL BIOLOGY AND MEDICINE
- Long-term renal outcomes in a cohort of 1814 Chinese patients with biopsy-proven lupus nephritis
- (2015) J Yang et al. LUPUS
- Murine and Human Lupus Nephritis: Pathogenic Mechanisms and Theoretical Strategies for Therapy
- (2015) Hege Lynum Pedersen et al. SEMINARS IN NEPHROLOGY
- New insights into the pathogenesis and management of lupus in children
- (2014) A. Midgley et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Nrf-2–HO-1–HMGB1 axis: An important therapeutic approach for protection against myocardial ischemia and reperfusion injury
- (2014) Jichun Wang et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Opposing Impact of B Cell-Intrinsic TLR7 and TLR9 Signals on Autoantibody Repertoire and Systemic Inflammation
- (2014) S. W. Jackson et al. JOURNAL OF IMMUNOLOGY
- The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus
- (2014) Dubravka Bobek et al. Pediatric Rheumatology
- The Pathogenesis of Lupus Nephritis
- (2013) M. Lech et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Surface expression and genotypes of Toll-like receptors 2 and 4 in patients with juvenile idiopathic arthritis and systemic lupus erythematosus
- (2013) Martina Kirchner et al. Pediatric Rheumatology
- Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation
- (2011) Pei-Yi Tsai et al. FREE RADICAL BIOLOGY AND MEDICINE
- B- to Plasma-Cell Terminal Differentiation Entails Oxidative Stress and Profound Reshaping of the Antioxidant Responses
- (2010) Milena Bertolotti et al. ANTIOXIDANTS & REDOX SIGNALING
- TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy
- (2010) S.A. Summers et al. JOURNAL OF AUTOIMMUNITY
- Critical Role of TLR2 and TLR4 in Autoantibody Production and Glomerulonephritis in lpr Mutation-Induced Mouse Lupus
- (2009) A. Lartigue et al. JOURNAL OF IMMUNOLOGY
- CXCR4/CXCL12 Hyperexpression Plays a Pivotal Role in the Pathogenesis of Lupus
- (2009) A. Wang et al. JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started